For over 90 years, Novo Nordisk, a global healthcare company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. Our history, along with our patient-centric approach, helps us advance the understanding and treatment of obesity. We lead initiatives and collaborate with other organizations to enhance obesity research, education and advocacy. We’ve built our business on the conviction that the formula for lasting success is staying focused, thinking long-term and doing business in a financially, socially and environmentally responsible way. For more information, visit novonordisk.us and @novonordiskus.